🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neurotoxicity

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy NCT07095998NA2 sites📍 Boston📍 Boston Ka-Wai Ho · Tests: Threshold Tracking Nerve Conduction Studies Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome NCT06895473Phase 21 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Cytarabine, Lumbar Puncture, Methotrexate, Therapeutic Hydrocortisone Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery NCT07767981n/a1 site📍 Chicago University of Chicago Atamparib in Patients With Advanced Solid Tumors NCT07374419Phase 1, Phase 21 site📍 Shanghai Nerviano Medical Sciences (Shanghai) Ltd. · Tests: atamparib escalation levels, atamparib RP2D Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia NCT05519579Phase 21 site📍 Atlanta Northside Hospital, Inc. · Tests: Methotrexate, Blinatumomab Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations NCT05089604Phase 41 site📍 Vancouver University of British Columbia · Tests: Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release Oral Tablet "The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients" NCT06679387Phase 21 site📍 Cairo Ain Shams University · Tests: Memantine-HCl, Placebo Oral Tablet Chemotherapy Induced Peripheral Neurotoxicity (CIPN): Why Should we Care NCT04986891n/a1 site📍 Monza University of Milano Bicocca Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy NCT07558447NA1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: CIPN assessment, EV blood analysis Multimodal Assessment of Cryotherapy for Paclitaxel-Induced Neuropathy NCT07780955NA4 sites📍 Bolzano📍 Brixen📍 Bruneck Azienda Sanitaria dell'Alto Adige · Tests: Cryotherapy A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity NCT06144151n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: NeurOptics® NPi®-300 Pupillometer International CIPN Assessment and Validation Study NCT04633655n/a30 sites📍 Birmingham📍 Atlanta📍 Baltimore University of Milano Bicocca · Tests: outcome measures for CIPN testing A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma NCT07106671Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Siltuximab rTMS as an Intervention for Levodopa-induced Dyskinesia NCT06570824NA1 site📍 Hvidovre Danish Research Centre for Magnetic Resonance · Tests: active TMS, sham TMS A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy NCT07249528n/a8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Audio Tasks Neuroimaging and Biomarkers of Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy NCT07075523n/a1 site📍 La Jolla University of California, San Diego · Tests: Brain magnetic resonance imaging, neurocognitive assessments, quality of life questionnaire, biomarkers Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome NCT05643092n/a1 site📍 Shijiazhuang zhang shoulong Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma NCT06421675Phase 26 sites📍 Vancouver📍 Victoria📍 Hamilton Ontario Clinical Oncology Group (OCOG) · Tests: Elranatamab injection Prospective Neurobehavioral Functions in Newly-diagnosed Patients With Primary CNS Lymphoma Treated With Hyperfractionated Conformal Whole-brain Radiation Therapy Plus Simultaneous Integrated Boost NCT04006561n/a1 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radi… Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study NCT07169487Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Methylene Blue Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome NCT06706102Phase 41 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: Biological tests, MRI, Neuropsychological tests Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis NCT05990881Phase 31 site📍 Providence Rhode Island Hospital · Tests: Botulinum toxin, Standard-of-care corticosteroid injections Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 NCT06649474NA1 site📍 Clermont-Ferrand University Hospital, Clermont-Ferrand · Tests: assess the serum HMGB1 concentrations before and after an oxaliplatin-based chemotherapy Delayed Toxicities Post-CAR-T NCT07665307n/a3 sites📍 San Francisco📍 New York📍 New York Icahn School of Medicine at Mount Sinai Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy NCT07173166NA2 sites📍 Valencia📍 Valencia Instituto de Investigacion Sanitaria INCLIVA · Tests: Physical activity, Physical activity and nutrition Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors NCT07357636n/a6 sites📍 Fuzhou📍 Guangzhou📍 Sanya Shantou University Medical College Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma NCT05972135Phase 217 sites📍 Tucson📍 Denver📍 Denver SCRI Development Innovations, LLC · Tests: Teclistamab, Talquetamab, Tocilizumab, Oral Dexamethasone Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy NCT05237986n/a3 sites📍 Los Angeles📍 Bethesda📍 Seattle National Cancer Institute (NCI) Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812NA1 site📍 Boston Beth Israel Deaconess Medical Center · Tests: DCog Short Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy NCT07390071NA1 site📍 Salt Lake City University of Utah · Tests: Home Automated Telemanagement (HAT) Patient Unit
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy